Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Nuclear chromatin characteristics of breast solid pattern ductal carcinoma in situ.

Frank DH, Davis JR, Alberts DS, Thompson D, Liu Y, Bartels PH.

Anal Quant Cytol Histol. 2001 Dec;23(6):418-26.

PMID:
11777277
2.

Quantitative study of breast cancer progression: different pathways for various in situ cancers.

Mariuzzi L, Mombello A, Granchelli G, Rucco V, Tarocco E, Frank D, Davis J, Thompson D, Bartels H, Mariuzzi GM, Bartels PH.

Mod Pathol. 2002 Jan;15(1):18-25.

3.
4.
5.
6.

Value of cytometric analysis for distinction of intraductal carcinoma of the breast.

Fisher ER, Siderits R.

Breast Cancer Res Treat. 1992;21(3):165-72.

PMID:
1325216
7.

Karyometry of infiltrating breast lesions.

Frank DH, Davis JR, Ranger-Moore J, Liu Y, Bartels HG, Alberts DS, Bartels PH.

Anal Quant Cytol Histol. 2005 Aug;27(4):195-201.

PMID:
16220830
8.
11.

Amplification of growth regulatory genes in intraductal breast cancer is associated with higher nuclear grade but not with the progression to invasiveness.

Glöckner S, Lehmann U, Wilke N, Kleeberger W, Länger F, Kreipe H.

Lab Invest. 2001 Apr;81(4):565-71.

PMID:
11304576
12.

Comparison of cytomorphological and architectural heterogeneity in mammographically-detected ductal carcinoma in situ.

Harrison M, Coyne JD, Gorey T, Dervan PA.

Histopathology. 1996 May;28(5):445-50.

PMID:
8735720
13.

Classification of ductal carcinoma in situ by gene expression profiling.

Hannemann J, Velds A, Halfwerk JB, Kreike B, Peterse JL, van de Vijver MJ.

Breast Cancer Res. 2006;8(5):R61.

14.

Ductal carcinoma in situ: a proposal for a new classification.

Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, Zafrani B.

Semin Diagn Pathol. 1994 Aug;11(3):167-80. Review.

PMID:
7831528
15.

Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer.

Mariuzzi L, Mombello A, Rucco V, Morelli L, Zamò A, Thompson D, Vaught L, Bartels HG, Mariuzzi G, Bartels PH.

Adv Clin Path. 2000 Apr;4(2):87-97.

PMID:
11080789
16.

Variable stromal periductular expression of CD34 and smooth muscle actin (SMA) in intraductal carcinoma of the breast.

Catteau X, Simon P, Vanhaeverbeek M, Noël JC.

PLoS One. 2013;8(3):e57773. doi: 10.1371/journal.pone.0057773. Epub 2013 Mar 1.

17.

Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.

Chuaqui RF, Zhuang Z, Emmert-Buck MR, Liotta LA, Merino MJ.

Am J Pathol. 1997 Jan;150(1):297-303.

18.

Ductal carcinoma in situ of the breast: a new phenotype classification system and its relation to prognosis.

Wärnberg F, Casalini P, Nordgren H, Bergkvist L, Holmberg L, Ménard S.

Breast Cancer Res Treat. 2002 Jun;73(3):215-21.

PMID:
12160327
19.

Nuclear cytometric changes in breast carcinogenesis.

Mommers EC, Poulin N, Sangulin J, Meijer CJ, Baak JP, van Diest PJ.

J Pathol. 2001 Jan;193(1):33-9.

PMID:
11169513
20.

[Clinicopathologic observation of carcinomas arising in fibroepithelial neoplasms of the breast].

Yang G, Guo L, Jin H, Li J, Ding H.

Zhonghua Bing Li Xue Za Zhi. 2014 Jul;43(7):437-41. Chinese.

PMID:
25327790

Supplemental Content

Support Center